LTR Pharma recently announced the dosing of the first patients in the Phase II study of SPONTAN ®, which is evaluating the ...
Aspire Allergy & Sinus Dr. Haley Overstreet highlights new research on needle-free treatment for severe allergic reactions. Epinephrine saves lives—but too often, hesitation gets in the way. A ...
Detailed price information for Vistagen Therapeutics Inc (VTGN-Q) from The Globe and Mail including charting and trades.
15don MSN
Intranasal vaccine booster shows stronger immune response and protection against sarbecoviruses
Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Monash University in Australia have demonstrated that an intranasal vaccine booster may confer ...
In a phase I trial, an intranasal adjuvanted recombinant influenza vaccine appeared to result in response to a range of H5N1 clades. The adjuvanted vaccine elicited seroconversion against clade 2 ...
REPORTS YEAR OF STRATEGIC TRANSFORMATION AND CLINCIAL ADVANCEMENTSARASOTA, Fla., March 17, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE ...
Morning Overview on MSN
New seasonal allergy treatments show promise, but no cure yet
A string of FDA approvals and late-stage clinical trials has expanded the toolkit for treating seasonal and environmental ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. This use of intranasal corticosteroids (INCs) does not ...
August 9, 2010 — The most frequent pediatric indications for intranasal medication delivery are pain control, anxiolysis, and seizure control, according to a review published online August 9 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results